These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9271167)

  • 1. Human IgG binding ability of streptococcal M3 protein: its related complement activation-dependent M3 protein polymerization.
    Hong K
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):163-74. PubMed ID: 9271167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCM, the M Protein of
    Bergmann S; Eichhorn I; Kohler TP; Hammerschmidt S; Goldmann O; Rohde M; Fulde M
    Front Cell Infect Microbiol; 2017; 7():80. PubMed ID: 28401063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of M3 protein expressed on the surface of group A streptococcal type 3 strain C203.
    Hong K; Komurasaki Y; Kobayashi H; Ishikawa H; Inoue K
    FEMS Immunol Med Microbiol; 1995 Sep; 12(1):73-82. PubMed ID: 8580905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity.
    Su YF; Chuang WJ; Wang SM; Chen WY; Chiang-Ni C; Lin YS; Wu JJ; Liu CC
    Mol Immunol; 2011 Oct; 49(1-2):134-42. PubMed ID: 21925735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets.
    Berge A; Kihlberg BM; Sjöholm AG; Björck L
    J Biol Chem; 1997 Aug; 272(33):20774-81. PubMed ID: 9252400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complex binding Streptococcus pyogenes type M12/emm12 in experimental glomerulonephritis.
    Burova L; Pigarevsky P; Duplik N; Snegova V; Suvorov A; Schalen C; Totolian A
    J Med Microbiol; 2013 Sep; 62(Pt 9):1272-1280. PubMed ID: 23788594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG F(ab')2 of rabbit anti-M sera but not the unfractionated sera are bactericidal for some group A streptococci with IgG Fc-receptor activity. Opsonic effect ascribable to anti-IgG.
    Schalén C; Burova LA; Christensen P; Grubb R; Samuelsson G; Svensson ML
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):247-52. PubMed ID: 7032207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.
    Muñoz E; Vidarte L; Pastor C; Casado M; Vivanco F
    Eur J Immunol; 1998 Aug; 28(8):2591-7. PubMed ID: 9710236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions.
    Berneman A; Belec L; Fischetti VA; Bouvet JP
    Infect Immun; 1998 Sep; 66(9):4163-8. PubMed ID: 9712763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human IgG Increases Virulence of
    Ermert D; Weckel A; Magda M; Mörgelin M; Shaughnessy J; Rice PA; Björck L; Ram S; Blom AM
    J Immunol; 2018 May; 200(10):3495-3505. PubMed ID: 29626087
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental poststreptococcal glomerulonephritis elicited by IgG Fc-binding M family proteins and blocked by IgG Fc fragment.
    Burova L; Pigarevsky P; Seliverstova V; Gupalova T; Schalén C; Totolian A
    APMIS; 2012 Mar; 120(3):221-30. PubMed ID: 22339680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.
    Eisenberg RA; Schwab JH
    Infect Immun; 1986 Aug; 53(2):324-30. PubMed ID: 3089935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.
    Jarvis GA; Griffiss JM
    J Immunol; 1991 Sep; 147(6):1962-7. PubMed ID: 1909736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
    Whitnack E; Dale JB; Beachey EH
    J Exp Med; 1984 Apr; 159(4):1201-12. PubMed ID: 6368736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin.
    Reglinski M; Gierula M; Lynskey NN; Edwards RJ; Sriskandan S
    Sci Rep; 2015 Oct; 5():15825. PubMed ID: 26508447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins.
    Säll A; Sjöholm K; Waldemarson S; Happonen L; Karlsson C; Persson H; Malmström J
    J Proteome Res; 2015 Nov; 14(11):4704-13. PubMed ID: 26452057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
    Carlsson F; Berggård K; Stålhammar-Carlemalm M; Lindahl G
    J Exp Med; 2003 Oct; 198(7):1057-68. PubMed ID: 14517274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.